Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 15074415

Detection performance of a diffusive wave phased array.

Stephen P Morgan
View original source ↗Export metadata ↓

Abstract

Diffusive wave phased arrays have been demonstrated to be a sensitive method of detecting inhomogeneities embedded in heavily scattering media. However, the increase in sensitivity is coupled with an increase in noise, so that the optimum performance may not be obtained when the sources are modulated in antiphase. The performance of a range of configurations in the presence of Gaussian noise is investigated by using probabilistic detection theory. A model of diffusive wave propagation through scattering media is used to demonstrate that the phase performance can be improved by controlling the relative phase difference between the two sources. However, the best performance is obtained by using the amplitude response of a single source system. The major benefit of a phased array system is therefore the rejection of common systematic noise.

Explore related subjects

ArtifactsDiagnostic ImagingModels, StatisticalModels, TheoreticalOptics and PhotonicsScattering, RadiationJournal ArticleResearch Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Stephen P Morgan. 2004-04-01. Detection performance of a diffusive wave phased array.. https://doi.org/10.1364/ao.43.002071

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Striping artifact removal in VisiumHD data through nuclear counts modeling.

MOTIVATION: 10x Genomics VisiumHD enables spatial transcriptomics at 2 µm × 2 µm resolution but exhibits slide-specific, non-periodic striping artifacts due to lane-width variability. These multiplicative row/column effects distort bin total counts and can bias downstream analyses. The state-of-the-art destriping approach is the normalization procedure used as a preprocessing step in bin2cell; it applies sequential high-quantile row- then column-wise normalization, which is asymmetric and can introduce edge effects/macro-stripes and distortions of large-scale total-count structure. RESULTS: We propose a statistical destriping approach that leverages nuclei segmentation from the co-registered H&E image. Assuming transcript abundance is constant within each nucleus, we model bin counts with a negative binomial distribution whose mean is a product of a nucleus-specific concentration and row- and column-specific stripe-factors reflecting lane-width variation. We fit all parameters in a generalized linear modeling framework with cross-validated regularization on stripe-factors and iterative dispersion estimation, and use the fitted parameters to correct the observed counts into a destriped image. On synthetic data with known ground truth, our method improves stripe-factor estimation accuracy and reduces error in corrected counts relative to bin2cell and bin2cell-derived baselines. Across four public VisiumHD slides, it consistently lowers striping intensity while substantially better preserving biological signal present in the large-scale global count structure and avoiding the artifacts introduced by other methods. AVAILABILITY AND IMPLEMENTATION: All source code and links to publicly available data used for this study are available at https://github.com/paolamalsot/destriping-GLM.

Artifacts↗
PubMed2007

Cleavage of cystatin C is not associated with multiple sclerosis.

Recently, Irani and colleagues proposed a C-terminal cleaved isoform cystatin C (12.5 kDa) in cerebrospinal fluid as a marker of multiple sclerosis. In this study, we demonstrate that the 12.5 kDa product of cystatin C is formed by degradation of the first eight N-terminal residues. Moreover, such a degradation is not specific in the cerebrospinal fluid of multiple sclerosis, but rather is given by an inappropriate sample storage at -20 degrees C. We conclude that the use of the 12.5 kDa product of cystatin C in cerebrospinal fluid might lead to a fallacious diagnosis of multiple sclerosis. Preanalytical validation procedure is mandatory for proteomics investigations.

Artifacts↗